MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.bbrc.2026.153965

Медицинская библиотека · Biochemical and biophysical research communications · 2026

Exogenous klotho as an adjunct to dapagliflozin ameliorates diabetic kidney disease by restoring mitophagy and mitigating apoptosis and fibrosis.

Rakshe Pratik Shankar, Gaikwad Anil Bhanudas

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Diabetic kidney disease (DKD) is a growing global health concern arising as a secondary microvascular complication of diabetes. Despite current therapeutic approaches, significant residual risk persists, highlighting need for an improved treatment strategy. Impaired mitophagy, apoptosis, and fibrosis are key pathomechanisms in DKD progression. The present study aims to investigate the therapeutic potential of novel recombinant human klotho (rh-KL)-dapagliflozin (DAPA) combination in both streptozotocin-induced Type 1 diabetes in Sprague-Dawley rats and high-glucose+recombinant human TGF-β1(HG+rh-TGF-β1)-stimulated NRK-52E cells DKD model. Following treatment, urine, plasma, and renal tissues were harvested and analyzed for biochemical, histological, immunohistochemical, and qRT-PCR analysis. Furthermore, siRNA-mediated klotho knockdown was performed to elucidate its specific role in regulating apoptosis and fibrotic progression in DKD. The combination therapy of rh-KL and DAPA significantly improved metabolic, renal function, and histological analysis demonstrated marked preservation of renal architecture. The co-treatment significantly increased SIRT1, PGC-1α, PINK1, Parkin, and Bcl-2 expression and reduced TGF-β and NF-κB levels in diabetic rats, as evidenced by immunohistochemistry and qRT-PCR. Moreover, combination therapy significantly reduced vimentin, collagen-I, and Bax expression in NRK-52E cells, as confirmed by immunocytochemistry and qRT-PCR analyses. Collectively, the combination therapy showed greater potential than monotherapies to restore mitophagy, inhibit apoptosis, and fibrosis. Further, klotho knockdown confirmed its protective role in DKD, as reduced klotho expression was associated with exacerbated apoptosis and fibrosis under diabetic conditions. This evidence indicates that the rh-KL and DAPA combination enhances renoprotective effects and allows a lower DAPA dose, potentially minimizing adverse effects while improving overall therapeutic outcomes in DKD.

Для цитирования: Rakshe Pratik Shankar, Gaikwad Anil Bhanudas. Exogenous klotho as an adjunct to dapagliflozin ameliorates diabetic kidney disease by restoring mitophagy and mitigating apoptosis and fibrosis.. Biochemical and biophysical research communications. 2026. DOI: 10.1016/j.bbrc.2026.153965.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.